生物谷報(bào)道：根據(jù)美國(guó)國(guó)家科學(xué)院院刊 (PNAS)最新一期的一份報(bào)告指出，由美國(guó)耶魯大學(xué) (Yale University)與羅得島大學(xué) (University of Rhode Island) 共同發(fā)展出來(lái)的一項(xiàng)新技術(shù),，可以利用小片段的蛋白質(zhì)，像奈米針筒一樣將標(biāo)示(tags) 黏附到腫瘤細(xì)胞上,，臨床上不但可以藉此標(biāo)示分裂失序的腫瘤細(xì)胞，未來(lái)還有可能因此發(fā)展出更有效的腫瘤治療方法。
參與這次研究計(jì)劃的科學(xué)家表示，這種稱為 pHLIP(pH (Low) Insertion Peptide)的蛋白質(zhì)片段,，可以用注射的方式，進(jìn)入罹患乳癌腫瘤細(xì)胞的小鼠腹部,，大約經(jīng)過(guò)20個(gè)小時(shí)的時(shí)間,，pHLIP分子會(huì)經(jīng)由血管的輸送,，累積于乳癌腫瘤細(xì)胞內(nèi),。
就目前的實(shí)驗(yàn)數(shù)據(jù)看來(lái),，此分子的專一性非常的高，因此再小的腫瘤組織,，都會(huì)被發(fā)現(xiàn)并且囤積pHLIP分子,，研究人員可以利用熒光探針的方法，標(biāo)示pHLIP分子,，透過(guò)追蹤熒光的位置,，就等于發(fā)現(xiàn)癌細(xì)胞的落腳處，此外利用pHLIP分子,，攜帶有效的抗癌藥物,，那么就算是再隱蔽的癌細(xì)胞，都躲不過(guò)pHLIP分子的追殺,。
參與的科學(xué)家表示,，pHLIP分子的活動(dòng)，原則上是以組織變酸的變化,，作為篩選的工具,，因此應(yīng)該不僅僅只有酸化的癌細(xì)胞可用，將來(lái)連因組織發(fā)炎而導(dǎo)致酸化的關(guān)結(jié)炎,、局部缺血與中風(fēng),，都有可能因此找到新的治療方法。
原始出處:
Published online before print May 1, 2007, 10.1073/pnas.0702439104
PNAS | May 8, 2007 | vol. 104 | no. 19 | 7893-7898
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo
Oleg A. Andreev*,, Allison D. Dupuy, Michael Segala*, Srikanth Sandugu*, David A. Serra, Clinton O. Chichester, Donald M. Engelman,¶, and Yana K. Reshetnyak*,,¶
*Physics Department, University of Rhode Island, 2 Lippitt Road, Kingston, RI 02881; Department of Molecular Biophysics and Biochemistry, Yale University, P.O. Box 208114, New Haven, CT 06520; Research Office, University of Rhode Island, 70 Lower College Road, Kingston, RI 02881; and Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Fogarty Hall, 41 Lower College Road, Kingston, RI 02881
Contributed by Donald M. Engelman, March 17, 2007 (received for review December 19, 2006)
Abstract
The pH-selective insertion and folding of a membrane peptide, pHLIP [pH (low) insertion peptide], can be used to target acidic tissue in vivo, including acidic foci in tumors, kidneys, and inflammatory sites. In a mouse breast adenocarcinoma model, fluorescently labeled pHLIP finds solid acidic tumors with high accuracy and accumulates in them even at a very early stage of tumor development. The fluorescence signal is stable for >4 days and is approximately five times higher in tumors than in healthy counterpart tissue. In a rat antigen-induced arthritis model, pHLIP preferentially accumulates in inflammatory foci. pHLIP also maps the renal cortical interstitium; however, kidney accumulation can be reduced significantly by providing mice with bicarbonate-containing drinking water. The peptide has three states: soluble in water, bound to the surface of a membrane, and inserted across the membrane as an -helix. At physiological pH, the equilibrium is toward water, which explains its low affinity for cells in healthy tissue; at acidic pH, titration of Asp residues shifts the equilibrium toward membrane insertion and tissue accumulation. The replacement of two key Asp residues located in the transmembrane part of pHLIP by Lys or Asn led to the loss of pH-sensitive insertion into membranes of liposomes, red blood cells, and cancer cells in vivo, as well as to the loss of specific accumulation in tumors. pHLIP nanotechnology introduces a new method of detecting, targeting, and possibly treating acidic diseased tissue by using the selective insertion and folding of membrane peptides.
cancer targeting | imaging | peptide insertion
